150 related articles for article (PubMed ID: 28980517)
61. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
62. Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.
Wang YQ; Yang Y; Zhuo HY; Zou LQ; Jiang Y; Jiang M
Med Oncol; 2015 Feb; 32(2):435. PubMed ID: 25572807
[TBL] [Abstract][Full Text] [Related]
63. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.
Kim SJ; Yoon SE; Kim WS
J Hematol Oncol; 2018 Dec; 11(1):140. PubMed ID: 30567593
[TBL] [Abstract][Full Text] [Related]
64. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
[TBL] [Abstract][Full Text] [Related]
65. Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
Bennani NN; Tun AM; Carson KR; Geiger JL; Maeda LS; Savage KJ; Rose J; Pinter-Brown L; Lunning MA; Abramson JS; Bartlett NL; Vose JM; Evens AM; Smith SM; Horwitz SM; Ansell SM; Advani RH
Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):e250-e260. PubMed ID: 34794912
[TBL] [Abstract][Full Text] [Related]
66. [Therapy and prognosis analysis of 47 patients with extranodal NK/T-cell lymphoma].
Zhang SS; Wei M; Li HH; Jing Y; Li F; Huang WR; Lu XL; Liu ZX; Zhou Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):119-23. PubMed ID: 21362235
[TBL] [Abstract][Full Text] [Related]
67. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
[TBL] [Abstract][Full Text] [Related]
68. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
[TBL] [Abstract][Full Text] [Related]
69. Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma.
Tsai HJ; Lin SF; Chen CC; Chen TY; Su WC; Hwang WL; Lin JC; Chiou TJ; Kao WY; Chiu CF; Chang YF; Chang JS; Chang MC; Su IJ
Eur J Haematol; 2015 Feb; 94(2):130-7. PubMed ID: 24957163
[TBL] [Abstract][Full Text] [Related]
70. EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.
Lee JY; Kim JH; Bang H; Cho J; Ko YH; Kim SJ; Kim WS
Sci Rep; 2021 May; 11(1):10342. PubMed ID: 33990633
[TBL] [Abstract][Full Text] [Related]
71. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
72. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
[TBL] [Abstract][Full Text] [Related]
73. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
74. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
75. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
Xu YC; Chen KH; Liang ZG; Zhu XD
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
[TBL] [Abstract][Full Text] [Related]
76. Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
Bennani NN; Tun AM; Carson KR; Geiger JL; Maeda LS; Savage KJ; Rose J; Pinter-Brown L; Lunning MA; Abramson JS; Bartlett NL; Vose JM; Evens AM; Smith SM; Horwitz SM; Ansell SM; Advani RH
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e300-e309. PubMed ID: 34848181
[TBL] [Abstract][Full Text] [Related]
77. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?
Wu CC; Takahashi E; Asano N; Miyata-Takata T; Takata K; Furukawa K; Elsayed AA; Hu LM; Satou A; Kohno K; Kosugi H; Ohashi K; Kinoshita T; Nakamura S; Kato S
Hum Pathol; 2017 Oct; 68():61-68. PubMed ID: 28873353
[TBL] [Abstract][Full Text] [Related]
78. Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.
Chauchet A; Michallet AS; Berger F; Bedgedjian I; Deconinck E; Sebban C; Antal D; Orfeuvre H; Corront B; Petrella T; Hacini M; Bouteloup M; Salles G; Coiffier B
J Hematol Oncol; 2012 Jun; 5():27. PubMed ID: 22682004
[TBL] [Abstract][Full Text] [Related]
79. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
[TBL] [Abstract][Full Text] [Related]
80. Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type.
Zhang XX; Xie CH; Xu Y; Deng D; Zhao YH; Zou BW; Zhou L; Li M; Wang J; Liu WP; Huang MJ
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):747-52. PubMed ID: 19304409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
